Agouron Pharmaceuticals, which last month completed a...

Agouron Pharmaceuticals, which last month completed a $5-million private stock sale to an investor group led by New York-based Alan Patricof Assoc., has sold $2 million more in stock to Burr, Egan, Deleage & Co., a Boston-based investment firm.

Agouron reported an $845,800 net loss for the first quarter ended Sept. 30, contrasted with a $532,000 net loss during the like period a year ago. Revenue rose to $532,000, up from $171,600 a year ago.